Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
Antimicrobial Agents and Chemotherapy
|
October 3, 2007
Activity of a potent hepatitis C virus polymerase inhibitor in the chimpanzee model
Chih-Ming Chen, Yupeng He, Liangjun Lu, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 5, 2008
Hepatitis C NS5B polymerase inhibitors: 4,4-Dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivatives
Douglas K Hutchinson, Teresa Rosenberg, Larry L Klein, et al.
Journal of Medicinal Chemistry
|
May 29, 2007
Discovery of potent, selective, orally bioavailable stearoyl-CoA desaturase 1 inhibitors
Gang Liu, John K Lynch, Jennifer Freeman, et al.
Journal of Medicinal Chemistry
|
May 1, 2009
Synthesis and biological characterization of B-ring amino analogues of potent benzothiadiazine hepatitis C virus polymerase inhibitors
John T Randolph, Charles A Flentge, Peggy P Huang, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 14, 2013
Aryl uracil inhibitors of hepatitis C virus NS5B polymerase: synthesis and characterization of analogs with a fused 5,6-bicyclic ring motif
A Chris Krueger, John T Randolph, David A DeGoey, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 18, 2006
Discovery of adamantane ethers as inhibitors of 11beta-HSD-1: Synthesis and biological evaluation
Jyoti R Patel, Qi Shuai, Jurgen Dinges, et al.
Journal of Medicinal Chemistry
|
February 15, 2007
N-{3-[2-(4-alkoxyphenoxy)thiazol-5-yl]-1-methylprop-2-ynyl}carboxy derivatives as acetyl-coA carboxylase inhibitors--improvement of cardiovascular and neurological liabilities via structural modifications
Yu Gui Gu, Moshe Weitzberg, Richard F Clark, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 6, 2007
Pyrrolidine-constrained phenethylamines: The design of potent, selective, and pharmacologically efficacious dipeptidyl peptidase IV (DPP4) inhibitors from a lead-like screening hit
Bradley J Backes, Kenton Longenecker, Gregory L Hamilton, et al.
Journal of Medicinal Chemistry
|
April 14, 2006
2,4-diaminopyrimidine derivatives as potent growth hormone secretagogue receptor antagonists
Michael D Serby, Hongyu Zhao, Bruce G Szczepankiewicz, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 24, 2005
Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes
Peer B Jacobson, Thomas W von Geldern, Lars Ohman, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
Antimicrobial Agents and Chemotherapy
|
October 3, 2007
Activity of a potent hepatitis C virus polymerase inhibitor in the chimpanzee model
Chih-Ming Chen, Yupeng He, Liangjun Lu, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 5, 2008
Hepatitis C NS5B polymerase inhibitors: 4,4-Dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivatives
Douglas K Hutchinson, Teresa Rosenberg, Larry L Klein, et al.
Journal of Medicinal Chemistry
|
May 29, 2007
Discovery of potent, selective, orally bioavailable stearoyl-CoA desaturase 1 inhibitors
Gang Liu, John K Lynch, Jennifer Freeman, et al.
Journal of Medicinal Chemistry
|
May 1, 2009
Synthesis and biological characterization of B-ring amino analogues of potent benzothiadiazine hepatitis C virus polymerase inhibitors
John T Randolph, Charles A Flentge, Peggy P Huang, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 14, 2013
Aryl uracil inhibitors of hepatitis C virus NS5B polymerase: synthesis and characterization of analogs with a fused 5,6-bicyclic ring motif
A Chris Krueger, John T Randolph, David A DeGoey, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 18, 2006
Discovery of adamantane ethers as inhibitors of 11beta-HSD-1: Synthesis and biological evaluation
Jyoti R Patel, Qi Shuai, Jurgen Dinges, et al.
Journal of Medicinal Chemistry
|
February 15, 2007
N-{3-[2-(4-alkoxyphenoxy)thiazol-5-yl]-1-methylprop-2-ynyl}carboxy derivatives as acetyl-coA carboxylase inhibitors--improvement of cardiovascular and neurological liabilities via structural modifications
Yu Gui Gu, Moshe Weitzberg, Richard F Clark, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 6, 2007
Pyrrolidine-constrained phenethylamines: The design of potent, selective, and pharmacologically efficacious dipeptidyl peptidase IV (DPP4) inhibitors from a lead-like screening hit
Bradley J Backes, Kenton Longenecker, Gregory L Hamilton, et al.
Journal of Medicinal Chemistry
|
April 14, 2006
2,4-diaminopyrimidine derivatives as potent growth hormone secretagogue receptor antagonists
Michael D Serby, Hongyu Zhao, Bruce G Szczepankiewicz, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 24, 2005
Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes
Peer B Jacobson, Thomas W von Geldern, Lars Ohman, et al.
Page
of 5